SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-09-002488
Filing Date
2009-07-14
Accepted
2009-07-14 16:28:13
Documents
10
Period of Report
2009-04-30

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10k-043009.htm 10-K 1851207
2 EMPLOYMENT AGREEMENT FOR STEVEN W. KING, DATED MARCH 18, 2009 peregrine_10k-ex1012.htm EX-10.12 112524
3 EMPLOYMENT AGREEMENT FOR PAUL J. LYTLE, DATED MARCH 18, 2009. peregrine_10k-ex1013.htm EX-10.13 117413
4 EMPLOYMENT AGREEMENT FOR JOSEPH SHAN, DATED MARCH 18, 2009. peregrine_10k-ex1014.htm EX-10.14 118181
5 EMPLOYMENT AGREEMENT FOR SHELLEY P.M. FUSSEY, PH.D., DATED MARCH 18, 2009. peregrine_10k-ex1015.htm EX-10.15 119125
6 SUBSIDIARIES OF REGISTRANT peregrine_10k-ex21.htm EX-21 3744
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM peregrine_10k-ex2301.htm EX-23.1 3430
8 CERTIFICATION peregrine_10k-ex3101.htm EX-31.1 12254
9 CERTIFICATION peregrine_10k-ex3102.htm EX-31.2 12603
10 CERTIFICATION peregrine_10k-ex32.htm EX-32 14395
  Complete submission text file 0001019687-09-002488.txt   2366480
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 09944115
SIC: 2835 In Vitro & In Vivo Diagnostic Substances